Verastem Oncology
VSTM
#8196
Rank
NZ$0.33 B
Marketcap
$7.42
Share price
-5.63%
Change (1 day)
-41.88%
Change (1 year)

Revenue for Verastem Oncology (VSTM)

Revenue in 2024 (TTM): NZ$16.41 Million

According to Verastem Oncology 's latest financial reports the company's current revenue (TTM ) is NZ$17.71 Million. In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of NZ$4.08 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verastem Oncology from 2011 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$16.41 M
2023 N/A-100%
2022 NZ$4.08 M36.04%
2021 NZ$3 M-97.55%
2020 NZ$0.12 B373.33%
2019 NZ$25.91 M-34.93%
2018 NZ$39.83 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NZ$18.17 M 2.59%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$106.50 B 601,010.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.52 B 127,028.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$71.31 B 402,427.07%๐Ÿ‡ฌ๐Ÿ‡ง UK